advertisement

---

Iannaccone A 1

Showing records 1 to 1 | Display all abstracts from Iannaccone A

126046 Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results
Yang P; Birch D; Lauer A; Sisk R; Anand R; Pennesi ME; Iannaccone A; Yaghy A; Scaria A; Jung JA; Curtiss D; Waheed NK
American Journal of Ophthalmology 2025; 271: 268-285

---